Translational Knowledge Discovery Between Drug Interactions and Pharmacogenetics
نویسندگان
چکیده
منابع مشابه
Translational Medicine and Drug Discovery
broad series of topics ranging from communication issues with patients to helping physicians deal with psychological and ethical issues. Although it is aimed at health care providers who care for patients facing serious illnesses, it is a relevant resource for anyone who wants to learn more about palliative care. Overall, Care at the Close of Life is a very informative and a must-read for those...
متن کاملEthnobotany, Ethnopharmacology and Drug Discovery
This manuscript is a review of a number of ethnobotany and ethnopharmacology texts and papers in order to arrive at current understanding and scope of ethnobotany and ethnopharmacology. It includes either a brief definition of both fields and presenting some examples on them. Also it has a glimpse on the geographical coverage of research works throughout the world, important issue of prope...
متن کاملDRUG EPIDEMIOLOGY, INTERACTIONS AND PHARMACOGENETICS A post-mortem database study
.........................................................................................................................................................8 INTRODUCTION............................................................................................................................................10 REVIEW OF THE LITERATURE .................................................................
متن کاملApplication of Machine Learning in Knowledge Discovery for Pharmaceutical Drug-drug Interactions
Artificial neural networks (ANNs) have been developed to predict the clinical significance of drug-drug interactions (DDIs) for a set of 35 pharmaceutical drugs using data compiled from the Web-based resources, Lexicomp® and Vidal®, with inputs furnished by various drug pharmacokinetic (PK) and/or pharmacodynamic (PD) properties, and/or drug-enzyme interaction data. Success in prediction of DDI...
متن کاملArylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery
Arylamine N-acetyltransferases (NATs) are polymorphic drug-metabolizing enzymes, acetylating arylamine carcinogens and drugs including hydralazine and sulphonamides. The slow NAT phenotype increases susceptibility to hydralazine and isoniazid toxicity and to occupational bladder cancer. The two polymorphic human NAT loci show linkage disequilibrium. All mammalian Nat genes have an intronless op...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Pharmacology & Therapeutics
سال: 2020
ISSN: 0009-9236,1532-6535
DOI: 10.1002/cpt.1745